Potential drug-like inhibitors of Group 1 influenza neuraminidase identified through computer-aided drug design

Comput Biol Chem. 2010 Apr;34(2):97-105. doi: 10.1016/j.compbiolchem.2010.03.005. Epub 2010 Apr 3.


Pandemic (H1N1) influenza poses an imminent threat. Nations have stockpiled inhibitors of the influenza protein neuraminidase in hopes of protecting their citizens, but drug-resistant strains have already emerged, and novel therapeutics are urgently needed. In the current work, the computer program AutoGrow is used to generate novel predicted neuraminidase inhibitors. Given the great flexibility of the neuraminidase active site, protein dynamics are also incorporated into the computer-aided drug-design process. Several potential inhibitors are identified that are predicted to bind to neuraminidase better than currently approved drugs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antiviral Agents / chemistry*
  • Drug Design*
  • Enzyme Inhibitors / chemistry*
  • Humans
  • Influenza A Virus, H1N1 Subtype / enzymology*
  • Influenza, Human / drug therapy
  • Molecular Dynamics Simulation
  • Neuraminidase / antagonists & inhibitors*
  • Neuraminidase / chemistry*


  • Antiviral Agents
  • Enzyme Inhibitors
  • Neuraminidase